Acetaminophen Anhydrous Basis And Chlorpheniramine Maleate
Generic Name: acetaminophen anhydrous basis and chlorpheniramine maleate
Dosage form: POWDER. Active ingredients: ACETAMINOPHEN (.9 kg/kg); CHLORPHENIRAMINE MALEATE (.0055 kg/kg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: ACETAMINOPHEN (.9 kg/kg); CHLORPHENIRAMINE MALEATE (.0055 kg/kg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Loncastuximab Tesirine
loncastuximab tesirine
11 DESCRIPTION Loncastuximab tesirine-lpyl is a CD19-directed antibody and alkylating agent conjugate, consisting of a humanized IgG1 kappa monoclonal antibody conjugated to SG3199, a pyrrolobenzodiazepine (PBD) dimer cytotoxic alkylating agent, through a protease-cleavable valine-alanine linker. SG3199 attached to the linker is designated as SG3249, also known as tesirine. Loncastuximab tesirine-lpyl has an approximate molecular weight of 151 kDa.
Rilpivirine Hcl
rilpivirine hcl
Dosage form: POWDER. Active ingredients: RILPIVIRINE HYDROCHLORIDE (100 kg/100kg). Category: BULK INGREDIENT.
Dorzolamide Hcl
dorzolamide hcl
11 DESCRIPTION Dorzolamide hydrochloride ophthalmic solution, USP is a carbonic anhydrase inhibitor formulated for topical ophthalmic use. Dorzolamide hydrochloride USP is described chemically as: (4 S-trans )-4-(ethylamino)-5,6-dihydro-6-methyl-4 H -thieno[2,3- b ]thiopyran-2-sulfonamide 7,7-dioxide monohydrochloride. Dorzolamide hydrochloride is optically active.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.